Abbott Laboratories stock traded at USD 101.09 on September 24, 2026, while analysts set an average

Follow Abbott Laboratories as investors assess medical devices and diagnostics, the current catalyst, execution risks and the company evidence that may shape its next market move.

At the close on September 24, 2026, Abbott Laboratories stock finished at USD 101.61 after a 1.82 pe

Abbott Laboratories recently announced an exclusive partnership with Berry Street that pairs its Lingo over the counter glucose monitor with insurance covered virtual nutrition coaching, while its Volt Pulsed Field Ablation System recorded first clinical use in both Canada and at UnityPoint Health in the US for atrial fibrillation procedures. This combination of consumer focused metabolic tracking through Lingo and expanding Volt PFA procedure use in electrophysiology reflects Abbott...

Abbott Laboratories stock posted adjusted EPS of USD 1.31 versus USD 1.28 consensus for Q2 2026 on J

Al cierre del 23 de septiembre de 2026, las acciones de Abbott Laboratories alcanzaron los USD 103,69 después de una caída del 0,69 por ciento.

Tributary Capital Management publicó su carta para inversores del segundo trimestre de 2026 para la “Estrategia de capital básico de capitalización múltiple”. Puede descargar una copia de la carta aquí. La asignación de acciones del Tributary Multi Cap Core tuvo un rendimiento inferior en el segundo trimestre, con un rendimiento del +12,5% frente al +15,3% del S&P 1500 y +15,4% del Russell 3000. La tecnología de la información fue el principal impulsor de […]

Abbott Laboratories recently announced an exclusive partnership with Berry Street that pairs its Lingo over the counter glucose monitor with insurance covered virtual nutrition coaching, while its Volt Pulsed Field Ablation System recorded first clinical use in both Canada and at UnityPoint Health in the US for atrial fibrillation procedures. This combination of consumer focused metabolic tracking through Lingo and expanding Volt PFA procedure use in electrophysiology reflects Abbott...

Al cierre del 23 de septiembre de 2026, las acciones de Abbott Laboratories terminaron a 103,69 dólares en la Bolsa de Nueva York, un aumento

Abbott Laboratories (ABT) has just seen its Volt Pulsed Field Ablation System move from approval to real world use, with first procedures reported in both Canada and the United States. For context, Abbott Laboratories is trading at US$103.69 after a 90 day share price return of 14.59%, even though the 1 year total shareholder return is down 21.93%. This points to momentum rebuilding in the short term after a tougher stretch for longer term holders. See how Abbott Laboratories compares with...

Abbott Laboratories stock closed at USD 104.13 on September 22, 2026, after a 1.12 percent gain. Tra

Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here. The fund highlighted a period of strong equity market gains as the S&P 500 surged ~17% following March’s selloff, driven by resilient earnings, artificial intelligence (AI) investment, and semiconductor strength. While acknowledging the strength of the AI-driven […]

Abbott Laboratories receives a Hold rating, as its current valuation reflects much of its business quality and future growth potential. Click for more on ABT.

Abbott Laboratories commands a premium price over faster-growing rivals, forcing investors to decide if its diversified business is worth more than pure-play growth.

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.